Qdem Pharmaceuticals

Qdem Pharmaceuticals is a UK-based pharmaceutical company that specializes in providing high-quality, cost-effective medicines to the National Health Service (NHS). As a member of the Napp Pharmaceutical Group, the company focuses primarily on pain management, offering a portfolio of branded generic analgesics. Their product range includes prolonged-release and immediate-release formulations of opioids such as oxycodone, morphine, and buprenorphine. Qdem aims to deliver value to healthcare providers by combining clinical efficacy with economic sustainability. The company leverages the extensive manufacturing and distribution infrastructure of its parent organization located in the Cambridge Science Park. By focusing on established molecules with proven safety profiles, Qdem ensures reliable access to essential treatments for patients suffering from chronic and severe pain.